Related Experiment Video
Updated: Jun 14, 2026
An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
Published on: October 10, 2025
[Intraorbital schwannomas and solitary neurofibromas]
1Département de neurochirurgie, hôpital Central, CHU de Nancy, 29, avenue de Lattre-de-Tassigny, 54000 Nancy, France. t.civit@chu-nancy.fr
Abstract:
Intraorbital schwannomas and solitary neurofibromas account for 2 to 5% of all operated intraorbital tumors. Without any known neurofibromatosis, their diagnosis is only suggested with the MRI data, which displays a heterogeneous signal that may mimic a cavernous angioma. Their treatment is solely surgical.
Insights
Intraorbital schwannomas and solitary neurofibromas are rare tumors diagnosed via MRI. These tumors, mimicking other conditions, require surgical intervention for treatment.
Area of Science:
- Ophthalmology
- Neurosurgery
- Radiology
Background:
- Schwannomas and solitary neurofibromas constitute 2-5% of operated intraorbital tumors.
- Diagnosis without known neurofibromatosis relies on MRI findings.
- These tumors can present with heterogeneous signals, potentially mimicking cavernous angiomas.
Purpose of the Study:
- To highlight the diagnostic challenges and treatment of intraorbital schwannomas and solitary neurofibromas.
Main Methods:
- Review of diagnostic criteria for intraorbital tumors.
- Analysis of MRI characteristics of schwannomas and neurofibromas.
- Evaluation of treatment outcomes for operated intraorbital tumors.
Main Results:
- MRI is crucial for suggesting the diagnosis of these tumors when neurofibromatosis is absent.
- Heterogeneous signal intensity on MRI can lead to differential diagnoses, including cavernous angioma.
- Surgical removal is the established treatment modality.
Conclusions:
- Accurate diagnosis of intraorbital schwannomas and neurofibromas relies heavily on advanced imaging like MRI.
- Distinguishing these tumors from other intraorbital lesions is critical for appropriate management.
- Surgical treatment remains the definitive approach for these rare tumors.
